Literature DB >> 7549850

Adverse reactions after measles vaccination in India.

D K Sood1, S Kumar, S Singh, J Sokhey.   

Abstract

BACKGROUND: One hundred and sixty million doses of measles vaccine have been used since the Expanded Programme of Immunization began in 1985. Mild-to-moderate vaccine reactions are not infrequent and are accepted by parents but occasionally severe reactions and even death occur. We studied these severe reactions.
METHODS: From 1986 to 1994, 1762 batches of measles vaccine were tested and found to be satisfactory by the World Health Organization criteria. These were released for mass immunization.
RESULTS: After 40 reported incidents of severe reactions or deaths in the field, 59 intact samples of vaccine produced by different manufacturers were tested and found to be safe, i.e. they were not toxic and were sterile. However, on testing reconstituted or used vials a few were found to be toxic and many were unsterile. Reactions occurred in 115 vaccinees resulting in death of 79 children. These reactions were characterized by high fever, vomiting and profuse watery diarrhoea resulting in death within 24 hours.
CONCLUSIONS: Reactions to the vaccines were more likely to be related to the toxic shock syndrome due to the use of unsterile syringes and needles and perhaps the use of reconstituted vaccines beyond their specified time for administration resulting in contamination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549850

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  5 in total

1.  Safety in laboratories: Indian scenario.

Authors:  Ajaz Mustafa; A Jan Farooq; Gj Qadri; Tabish S A
Journal:  Int J Health Sci (Qassim)       Date:  2008-07

2.  Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVacR).

Authors:  Prasad S Kulkarni; Suresh S Jadhav; F Marc LaForce
Journal:  Hum Vaccin Immunother       Date:  2017-12-01       Impact factor: 3.452

3.  International Consensus (ICON): allergic reactions to vaccines.

Authors:  Stephen C Dreskin; Neal A Halsey; John M Kelso; Robert A Wood; Donna S Hummell; Kathryn M Edwards; Jean-Christoph Caubet; Renata J M Engler; Michael S Gold; Claude Ponvert; Pascal Demoly; Mario Sanchez-Borges; Antonella Muraro; James T Li; Menachem Rottem; Lanny J Rosenwasser
Journal:  World Allergy Organ J       Date:  2016-09-16       Impact factor: 4.084

Review 4.  Sepsis, parenteral vaccination and skin disinfection.

Authors:  Ian F Cook
Journal:  Hum Vaccin Immunother       Date:  2016-06-13       Impact factor: 3.452

5.  Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.

Authors:  Patrick T Wedlock; Elizabeth A Mitgang; Sheryl S Siegmund; Jay DePasse; Jennifer Bakal; Jim Leonard; Joel Welling; Shawn T Brown; Bruce Y Lee
Journal:  Vaccine       Date:  2018-08-23       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.